VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / December 8, 2025 / SouthGobi Resources Ltd. (TSX-V:SGQ)(HK:1878) - ...
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure ...
IBM (NYSE: IBM) and Confluent, Inc. (NASDAQ: CFLT), the data streaming pioneer, today announced they have entered into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback